COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 2341: Articles 23401-23410  | Next

Racial and workplace disparities in seroprevalence of SARS-CoV-2 in Baton Rouge, Louisiana, July 15-31, 2020
Feehan, A. K., Velasco, C., Fort, D., Burton, J. H., Price-Haywood, E., Katzmarzyk, P. T., Garcia-Diaz, J., Seoane, L.
10.1101/2020.08.26.20180968 — Posted: 2020-09-01
Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia
Rosas, I., Bräu, N., Waters, M., Go, R. C., Hunter, B. D., Bhagani, S., Skiest, D., Aziz, M. S., Cooper, N., Douglas, I. S., Savic, S., Youngstein, T., Del Sorbo, L., Cubillo Gracian, A., De La Zerda, D. J., Ustianowski, A., Bao, M., Dimonaco, S., Graham, E., Matharu, B., Spotswood, H., Tsai, L., Malhotra, A.
10.1101/2020.08.27.20183442 — Posted: 2020-09-01 Discussion: Offsite
Potential reduction in transmission of COVID-19 by digital contact tracing systems
Plank, M. J., James, A., Lustig, A., Steyn, N., Binny, R. N., Hendy, S. C.
10.1101/2020.08.27.20068346 — Posted: 2020-09-01
Jumping back and forth: anthropozoonotic and zoonotic transmission of SARS-CoV-2 on mink farms
Oude Munnink, B. B., Sikkema, R. S., Nieuwenhuijse, D. F., Molenaar, R. J., Munger, E., Molenkamp, R., van der Spek, A., Tolsma, P., Rietveld, A., Brouwer, M., Bouwmeester-Vincken, N., Harders, F., Hakze-van der Honing, R., Wegdam-Blans, M. C. A., Bouwstra, R., GeurtsvanKessel, C., van der Eijk, A., Velkers, F., Smit, L., Stegeman, A., van der Poel, W. H. M., Koopmans, M.
10.1101/2020.09.01.277152 — Posted: 2020-09-01 Discussion: Offsite
A versatile reporter system to monitor virus infected cells and its application to dengue virus and SARS-CoV-2
Pahmeier, F., Neufeldt, C. J., Cerikan, B., Prasad, V., Pape, C., Laketa, V., Ruggieri, A., Bartenschlager, R., Cortese, M.
10.1101/2020.08.31.276683 — Posted: 2020-09-01
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro
Drayman, N., Jones, K. A., Azizi, S.-A., Froggatt, H. M., Tan, K., Ivanova Maltseva, N., Chen, S., Nicolaescu, V., Dvorkin, S., Furlong, K., Kathayat, R. S., Firpo, M. R., Mastrodomenico, V., Bruce, E. A., Schmidt, M. M., Jedrzejczak, R., Munoz-Alia, M. A., Schuster, B., Nair, V., Botten, J. W., Brooke, C. B., Baker, S. C., Mounce, B. C., Heaton, N. S., Dickinson, B. C., Jaochimiak, A., Randall, G., Tay, S.
10.1101/2020.08.31.274639 — Posted: 2020-09-01 Discussion: Onsite
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
Nayak, K., Gottimukkala, K., Kumar, S., Reddy, E. S., Edara, V. V., Kauffman, R., Floyd, K., Mantus, G., Savargaonkar, D., Goel, P. K., Arora, S., Rahi, M., Davis, C. W., Linderman, S., Wrammert, J., Suthar, M., Ahmed, R., Sharma, A., Murali-Krishna, K., Chandele, A.
10.1101/2020.08.31.276675 — Posted: 2020-09-01
Engineered Trimeric ACE2 Binds and Locks "Three-up" Spike Protein to Potently Inhibit SARS-CoVs and Mutants
Guo, L., Bi, W., Wang, X., Xu, W., Yan, R., Zhang, Y., Zhao, K., Li, Y., Zhang, M., Bao, X., Cai, X., Li, Y., Qu, D., Jiang, S., Xie, Y., Zhou, Q., Lu, L., Dang, B.
10.1101/2020.08.31.274704 — Posted: 2020-09-01
Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial
Avendano-Sola, C., Ramos-Martinez, A., Munez-Rubio, E., Ruiz-Antoran, B., Malo de Molina, R., Torres, F., Fernandez-Cruz, A., Callejas-Diaz, A., Calderon, J., Payares-Herrera, C., Salcedo, I., Romera, I., Lora-Tamayo, J., Mancheno-Losa, M., Paciello, M. L., Villegas, C., Estrada, V., Saez-Serrano, I., Porras-Leal, M. L., Jarilla-Fernandez, M. d. C., Pano-Pardo, J. R., Moreno-Chulilla, J. A., Arrieta-Aldea, I., Bosch, A., Belhassen-Garcia, M., Lopez-Villar, O., Ramos-Garrido, A., Blanco, L., Madrigal, M. E., Contreras, E., Muniz-Diaz, E., Domingo-Morera, J. M., Casas-Flecha, I., Perez-Olmeda, M., Garcia-Perez, J., Alcami, J., Bueno, J. L., Duarte, R. F.
10.1101/2020.08.26.20182444 — Posted: 2020-09-01
The importance of saturating density dependence for predicting SARS-CoV-2 resurgence
Nightingale, E., Brady, O. J., Yakob, L.
10.1101/2020.08.28.20183921 — Posted: 2020-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).